Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haoluowei
Shenzhen, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Haorui offers US FDA/EDQM/UK MHRA-approved APIs for global customers; recent inspection passed with zero observations
- Therapeutic areas
- OncologyNeurologyPsychiatry
- Modalities
- Small moleculeBiologicCosmetic ingredientFood additive
- Industry
- Contract Manufacturing Organization
02
Partnerships
Bioman (sister company)close engagement with CDMO companies globally
Beyond the preview
Go deeper on Haoluowei.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haoluowei.